Main trends of immune effects triggered by nanomedicines in preclinical studies

about

Main trends of immune effects triggered by nanomedicines in preclinical studies

Item

http://www.wikidata.org/entity/Q57074417

description

im Jahr 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Main trends of immune effects triggered by nanomedicines in preclinical studies

@en

Main trends of immune effects triggered by nanomedicines in preclinical studies

@nl

type

Item

label

Main trends of immune effects triggered by nanomedicines in preclinical studies

@en

Main trends of immune effects triggered by nanomedicines in preclinical studies

@nl

prefLabel

Main trends of immune effects triggered by nanomedicines in preclinical studies

@en

Main trends of immune effects triggered by nanomedicines in preclinical studies

@nl

P1476

Main trends of immune effects triggered by nanomedicines in preclinical studies

@en

P2093

Blanka Halamoda-Kenzaoui

http://www.w3.org/2001/XMLSchema#string

Susanne Bremer-Hoffmann

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidative stress and inflammatory response in dermal toxicity of single-walled carbon nanotubes

Understanding biophysicochemical interactions at the nano-bio interface

Anti-PEG immunity: emergence, characteristics, and unaddressed questions.

Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy

Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo

Cytokines as biomarkers of nanoparticle immunotoxicity

The alarmin IL-1α is a master cytokine in acute lung inflammation induced by silica micro- and nanoparticles

Immunotoxicity of silicon dioxide nanoparticles with different sizes and electrostatic charge

Immunotoxicity assessment of CdSe/ZnS quantum dots in macrophages, lymphocytes and BALB/c mice

Titanium dioxide nanoparticles stimulate sea urchin immune cell phagocytic activity involving TLR/p38 MAPK-mediated signalling pathway

P304

5419-5431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S168808

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30271138

http://www.w3.org/2001/XMLSchema#string

P921

drug discovery

bioengineering

Biofiseg

P932

6149906

http://www.w3.org/2001/XMLSchema#string